Product NDC: | 0187-0007 |
Proprietary Name: | Virazole |
Non Proprietary Name: | Ribavirin |
Active Ingredient(s): | 6 g/1 & nbsp; Ribavirin |
Administration Route(s): | RESPIRATORY (INHALATION) |
Dosage Form(s): | POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0187-0007 |
Labeler Name: | Valeant Pharmaceuticals North America LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018859 |
Marketing Category: | NDA |
Start Marketing Date: | 19860101 |
Package NDC: | 0187-0007-14 |
Package Description: | 4 VIAL, GLASS in 1 CARTON (0187-0007-14) > 1 POWDER, FOR SOLUTION in 1 VIAL, GLASS |
NDC Code | 0187-0007-14 |
Proprietary Name | Virazole |
Package Description | 4 VIAL, GLASS in 1 CARTON (0187-0007-14) > 1 POWDER, FOR SOLUTION in 1 VIAL, GLASS |
Product NDC | 0187-0007 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ribavirin |
Dosage Form Name | POWDER, FOR SOLUTION |
Route Name | RESPIRATORY (INHALATION) |
Start Marketing Date | 19860101 |
Marketing Category Name | NDA |
Labeler Name | Valeant Pharmaceuticals North America LLC |
Substance Name | RIBAVIRIN |
Strength Number | 6 |
Strength Unit | g/1 |
Pharmaceutical Classes | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |